ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.80
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,253.45
      -0.76%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Brooklyn ImmunoTherapeutics Inc (BTX)

      7. Brooklyn ImmunoTherapeutics Inc (BTX) News

      BTX

      Brooklyn ImmunoTherapeut... (BTX)

      Brooklyn ImmunoTherapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:BTX
      DateTimeSourceHeadlineSymbolCompany
      05/11/20234:35PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      05/10/20236:02AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      05/05/20237:02AMEdgar (US Regulatory)Annual Report to Security Holders (ars)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      05/05/20237:02AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      05/05/20237:01AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      05/05/20236:31AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      04/25/20239:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      04/20/20234:31PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      04/11/20237:31AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      04/04/20235:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      04/04/20235:05PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      03/21/20238:39AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      03/06/20234:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      01/26/20234:32PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      01/10/20234:31PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      01/04/20238:36AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      12/20/20224:31PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      12/16/20225:01PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      12/14/20224:31PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      12/06/20226:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      12/06/20224:31PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      12/05/20225:21PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      12/05/20226:04AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      12/02/20225:01PMEdgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      11/22/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      11/14/20224:57PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      10/24/20224:32PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      10/14/20224:34PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      10/11/20228:31AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
      09/23/20224:32PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
       Showing the most relevant articles for your search:AMEX:BTX